Skip to content
Riskpilot
← Back to search
Sign in
Get full access
BOEHRINGER INGELHEIM NORWAY MANAGEMENT AS
AS
Active
Org 981314913
Hagaløkkveien 26, 1383
Asker
Manufacture of basic pharmaceutical products
· NACE 2110
Est. 1999
0 employees
Watchlist
Share
Norway
/
Companies
/
Manufacture of basic pharmaceutical products
/
BOEHRINGER INGELHEIM NORWAY MANAGEMENT AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (1)
UM
Ulf Munack
Chief Executive Officer
Chief Executive Officer
2019 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
NR
Niko Rodio
Board of Directors
2023
SM
Stephen Mark Wright
Chairman
2023
MO
Merethe Off
Board of Directors
2023
Former (3)
MF
Morten Frimann Clausen
Board of Directors
2019 – 2022
AO
Arnt Ove Hovden
Chairman
2022 – 2023
MU
Maj Ulrika Henriksson
Board of Directors
2022 – 2023
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Boehringer Ingelheim International
Company
100%
100%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on BOEHRINGER INGELHEIM NORWAY MANAGEMENT AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
